trial · primary record
MRI, FDG-PET/CT scans
Neurofibromatosis
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2019-12-30 |
| Primary endpoint | Evaluate the feasibility of whole-exome sequencing and other genetic/genomic methods |
| Registry ID | NCT02211768 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:56.165Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02211768
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.